Michael Secora Recursion Pharmaceuticals, Inc. (RXRX) insider trading activity

RXRX Quotes by TradingView

Michael Secora is Chief Financial Officer of RECURSION PHARMACEUTICALS, INC.. Currently has a direct ownership of 1.49 Million shares of RXRX, which is worth approximately $8.93 Million. The most recent transaction as insider was on Jun 13, 2024, when has been sold 39,375 shares (Class A Common Stock) at a price of $2.22 per share, resulting in proceeds of $87,412. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.49M
9.92% 3M change
59.79% 12M change
Total Value Held $8.93 Million

Michael Secora Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 13 2024
BUY
Exercise of conversion of derivative security
$87,412 $2.22 p/Share
39,375 Added 3.03%
1,258,468 Class A Common Stock
May 15 2024
SELL
Payment of exercise price or tax liability
$119,739 $10.01 p/Share
11,962 Reduced 0.97%
1,219,093 Class A Common Stock
Apr 17 2024
SELL
Open market or private sale
$175,279 $7.58 p/Share
23,124 Reduced 1.84%
1,231,055 Class A Common Stock
Apr 17 2024
BUY
Exercise of conversion of derivative security
$83,250 $2.22 p/Share
37,500 Added 2.9%
1,254,179 Class A Common Stock
Apr 16 2024
SELL
Open market or private sale
$191,750 $7.67 p/Share
25,000 Reduced 2.01%
1,216,679 Class A Common Stock
Apr 16 2024
BUY
Exercise of conversion of derivative security
$83,250 $2.22 p/Share
37,500 Added 2.93%
1,241,679 Class A Common Stock
Mar 13 2024
SELL
Open market or private sale
$275,750 $11.03 p/Share
25,000 Reduced 2.03%
1,204,179 Class A Common Stock
Mar 13 2024
BUY
Exercise of conversion of derivative security
$83,250 $2.22 p/Share
37,500 Added 2.96%
1,229,179 Class A Common Stock
Mar 12 2024
SELL
Open market or private sale
$261,500 $10.46 p/Share
25,000 Reduced 2.05%
1,191,679 Class A Common Stock
Mar 12 2024
BUY
Exercise of conversion of derivative security
$83,250 $2.22 p/Share
37,500 Added 2.99%
1,216,679 Class A Common Stock
Feb 15 2024
SELL
Payment of exercise price or tax liability
$89,147 $12.43 p/Share
7,172 Reduced 0.6%
1,179,179 Class A Common Stock
Feb 14 2024
SELL
Open market or private sale
$267,750 $10.71 p/Share
25,000 Reduced 2.06%
1,186,351 Class A Common Stock
Feb 14 2024
BUY
Exercise of conversion of derivative security
$83,250 $2.22 p/Share
37,500 Added 3.0%
1,211,351 Class A Common Stock
Feb 13 2024
SELL
Open market or private sale
$246,500 $9.86 p/Share
25,000 Reduced 2.09%
1,173,851 Class A Common Stock
Feb 13 2024
BUY
Exercise of conversion of derivative security
$83,250 $2.22 p/Share
37,500 Added 3.03%
1,198,851 Class A Common Stock
Feb 09 2024
SELL
Payment of exercise price or tax liability
$25,346 $10.09 p/Share
2,512 Reduced 0.22%
1,161,351 Class A Common Stock
Feb 09 2024
BUY
Grant, award, or other acquisition
-
182,849 Added 13.58%
1,163,863 Class A Common Stock
Jan 17 2024
SELL
Open market or private sale
$256,250 $10.25 p/Share
25,000 Reduced 2.49%
981,014 Class A Common Stock
Jan 17 2024
BUY
Exercise of conversion of derivative security
$83,250 $2.22 p/Share
37,500 Added 3.59%
1,006,014 Class A Common Stock
Jan 16 2024
SELL
Open market or private sale
$261,249 $10.45 p/Share
25,000 Reduced 2.52%
968,514 Class A Common Stock
Jan 16 2024
BUY
Exercise of conversion of derivative security
$83,250 $2.22 p/Share
37,500 Added 3.64%
993,514 Class A Common Stock
Dec 13 2023
SELL
Open market or private sale
$189,750 $7.59 p/Share
25,000 Reduced 2.55%
956,014 Class A Common Stock
Dec 13 2023
BUY
Exercise of conversion of derivative security
$83,250 $2.22 p/Share
37,500 Added 3.68%
981,014 Class A Common Stock
Dec 12 2023
SELL
Open market or private sale
$184,750 $7.39 p/Share
25,000 Reduced 2.58%
943,514 Class A Common Stock
Dec 12 2023
BUY
Exercise of conversion of derivative security
$83,250 $2.22 p/Share
37,500 Added 3.73%
968,514 Class A Common Stock
MS

Michael Secora

Chief Financial Officer
Salt Lake City, UT

Track Institutional and Insider Activities on RXRX

Follow RECURSION PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RXRX shares.

Notify only if

Insider Trading

Get notified when an Recursion Pharmaceuticals, Inc. insider buys or sells RXRX shares.

Notify only if

News

Receive news related to RECURSION PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RXRX